Regulation of a high molecular weight microtubule-associated protein
 in PC12 cells by nerve growth factor by unknown
Regulation of a High  Molecular 
Microtu bu le-associated  Protein 
by Nerve Growth  Factor 
Weight 
in  PC12 Cells 
LLOYD  A.  GREENE, RONALD  K.  H.  LIEM, and  MICHAEL  L.  SHELANSKI 
Department of Pharmacology, New York University Medical Center, New York 70016 
AgSTrACT  PC12  rat pheochromocytoma cells respond to nerve growth factor (NGF) protein by 
shifting from  a chromaffin-cell-like  phenotype to a neurite-bearing  sympathetic-neuron-like 
phenotype. Comparison of the phosphoprotein patterns of the cells by SDS PAGE after various 
times of NGF treatment revealed  a high molecular weight (Mr ~  300,000) band whose relative 
intensity progressively  increased  beyond  2 d  of  NGF  exposure.  This  effect  was  blocked  by 
inhibitors of  RNA  synthesis  and  did  not require  neurite outgrowth  or substrate  attachment. 
The enhancement by NGF occurred  in serum-free  medium and was not produced by exposure 
to epidermal growth factor, insulin, dibutyryl cAMP, or dexamethasone. Several different types 
of experiments  indicated  that this  phosphoprotein  corresponds  to a high  molecular  weight 
(HMW)  microtubule-associated  protein (MAP). These included cross-reactivity with antiserum 
against  brain HMW MAPs, co-cycling with microtubules and co-assembly  with tubulin in the 
presence  of taxol. The  affected  species also co-migrated  in SDS PAGE gels with brain MAP1 
and, unlike MAP2, precipitated upon boiling. Studies with [3SS]-methionine-labeled  PC12 cells 
indicated that at least a significant proportion of this effect of NGF was due to increased  levels 
of protein rather than to mere enhancement of phosphorylation. On the basis of the apparent 
effects  of MAPs on the formation  and stabilization of microtubules and of the importance of 
microtubules  in  production  and  maintenance  of  neurites,  it is proposed  that induction  of a 
HMW  .MAP  may  be  one  of  the  steps  in  the  mechanism  whereby  NGF  promotes  neurite 
outgrowth.  Furthermore,  these findings may lead to an understanding of the role of MAP1  in 
the nervous system. 
One of the major actions of nerve growth factor protein (NGF) 
is the promotion of neurite outgrowth  and  regeneration (1). 
The  mechanistic steps by which NGF-responsive as well as 
other  neurons  produce  and  maintain  neurites  are  far  from 
clarified. The rat PC 12 pheochromocytoma cell line is a model 
system that has been employed to study neuronal differentia- 
tion  and,  in  particular, NGF's mechanisms of action (2,  3). 
PC 12 cells proliferate and express the phenotypic properties of 
adrenal chromaffin cells, their nonneoplastic counterparts. Ex- 
posure  of these  cells to  NGF  causes  an  alteration in  their 
phenotype so that they take on (over a  time course of days) 
numerous  characteristics of sympathetic neurons,  including 
outgrowth of long, branching neurites containing parallel ar- 
rays of microtubules (2, 4). A principal advantage of the PC 12 
line for examining NGF-promoted neurite outgrowth  is that 
the  ceils respond  to,  but  do  not  require  the  factor.  Hence, 
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unlike NGF-responsive neurons, which require NGF for sur- 
vival and are difficult to study before first exposure to NGF, 
PCI2 cells can be compared before and after various times of 
NGF treatment. 
Studies with PC 12 cells have revealed that neurite outgrowth 
in  this  system  is  blocked  by  inhibitors of transcription  (5). 
However, one- and two-dimensional SDS PAGE analyses of 
proteins synthesized by the cells before and after NGF treat- 
ment indicate no qualitative and only a  very limited number 
of quantitative changes (6-8). This has suggested that if tran- 
scription-dependent changes  in  protein synthesis are  indeed 
causally related to neurite outgrowth, then such changes must 
occur among the less abundant class of cellular proteins (6). 
In this study, we demonstrate that NGF selectively causes 
induction of a high molecular weight (HMW) phosphoprotein 
in PC I2 cultures and present evidence that this protein corre- 
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(MAP1) that has been previously identified in brain. 
MATERIALS  AND  METHODS 
Cell Culture 
PCI2  ceils  (passages  15-35)  were  grown  as  previously  described  (2)  on 
collagen-coated tissue culture dishes  in  the  presence or absence of 50 ng/ml 
NGF. For "suspension" cultures, the ceils were maintained with or without NGF 
on plastic Petri dishes. The ceils did not attach to these dishes, nor, when treated 
with NGF, did they grow neurites (9). Instead, they formed small clumps that 
floated in the medium or rested on the dish. All cultures were fed every 2  3 d. 
Radiolabeling 
[:~2P]-ORTHOPHOSPHATE:  The tissue culture medium was removed and the 
cell monolayers were washed two to three times with a phosphate-free, HEPES- 
buffered (pH 7.2) modified Krebs-Ringer saline (KRH; 10). The KRH was then 
replaced  with  KRH  supplemented  with  50-100 /tCi/ml  of carrier-free [:~2p]_ 
orthophosphate (New  England Nuclear, Boston, MA) and with or without 50 
ng/ml NGF and the cultures were incubated for 2 h  in a water-saturated 37°C 
atmosphere. At the end of incubation, the labeling saline was removed and the 
cultures were rapidly washed three times with phosphate-buffered saline (PBS; 11) 
and  the  ceils  processed  accordingly as  described  below.  For  ceils  grown in 
suspension, washing was carried out by low-speed centrifugation (200 g  for 5 
min). The cells were then suspended and incubated in KRH containing [a2p]_ 
orthophosphate and -+ NGF as above. At the end of incubation, the supernatant 
medium was removed and the cells were washed once with PBS, in both cases by 
low speed centrifugation as above. 
[~'~S]-METHIONINE:  Cultures were labeled in complete growth medium ± 
50 ng/ml NGF and with 100 #Ci/ml of [a~S]-methionine (1200 Ci/mmole; New 
England Nuclear) for 48-72 h. The medium was then removed, the cultures were 
rapidly washed three times with PBS and the ceils were processed as described 
below. 
Harvesting  for SDS PAGE 
For direct electrophoretic analysis, the cells were harvested by scraping in 
SDS-containing sample buffer (7), immediately boiled for 5 min, and then either 
analyzed the same day or stored frozen at -20°C until use the next day. 
Preparation of Anti-MAP Antiserum 
Microtubules were prepared from bovine brain by the method of Shelanski et 
al. (12) through two cycles of polymerization and depolymerization. The micro- 
tubule proteins were subsequently separated by SDS PAGE on 6% polyacryl- 
amide slabs (13), and the area of the gel corresponding to the HMW MAP bands 
(14-16) was excised, and used for immunizations. ~0.5 mg of total MAP protein 
mixed with complete Freund's adjuvant were used for the first immunization in 
a rabbit. ~0.2 mg of protein mixed with incomplete Freund's adjuvant were used 
for each boost. The rabbit was bled one week after each boost and the titer of the 
antiserum tested by radioimmunoassay using [12nil-labeled  MAP protein (17). A 
titer of 1:500 was determined by this method after the third boost. This antiserum 
was further tested by immunoblotting (18) against whole microtubule protein to 
determine the specificity of the antiserum. For these experiments microtubute 
proteins  prepared  by one  cycle of reassembly were  run  on  SDS  PAGE  (6% 
acrylamide), and transferred to nitrocellulose paper using a  Bio-Rad transblot 
apparatus (Bio-Rad Laboratories, Richmond, CA). The paper was subsequently 
incubated overnight with 5% bovine serum albumin to block nonspecific binding 
sites, followed by a  l-h incubation with antiserum (1:200 dilution in 5% BSA). 
The paper was washed five times with PBS, and incubated with biotinylated goat 
anti-rabbit (Vector Laboratories, Inc., Burlingame, CA) for 30 min. The paper 
was again washed five times with PBS, and incubated with avidin and biotinylated 
horse radish peroxidase for 30 rain. After five more washes with PBS, the paper 
was incubated with 0.03% diaminobenzidine (Sigma Chemical Co., St.  Louis, 
MO) and 0.005% H202 in 0.05 M Tris buffer, pH 7.8 to visualize the reaction. By 
this method, the antiserum recognized only the MAPI and MAP2 proteins. 
Immunoprecipitation  Experiments 
PCI2  cells  were  labeled  with  [~S]-methionine  or  [:~2P]-orthophosphate as 
described above, solubilized in  1% SDS containing 100 U/ml aprotinin and 0.5 
mM phenylmethanesulfonyl fluoride (PMSF; Sigma Chemical Co.), boiled for 5 
min, and sonicated to reduce viscosity. The numbers of TCA-precipitable counts 
in the preparations were determined and immunoprecipitation was carried out 
by modifications of previously described procedures (19).  Equal numbers of 
counts for the N.GF-treated and -untreated cells were incubated overnight at 4°C 
with  anti-MAP  antiserum  (1:20  dilution)  in  a  50  mM  Tris  buffer,  pH  7.4 
containing 0.19 M NaCI, 6 mM EDTA, 2.5% Triton X-100, 0.1% SDS, 100 U/ml 
aprotinin, and 0.5 mM  PMSF  (solutionA). In some experiments, excess brain 
MAP2 (1 mg/ml) was also present during incubation. The latter was prepared by 
the procedure of Herzog and Weber (20). For controls, preimmune serum was 
used. After incubation with the primary antibody, 0.1 ml of protein A-Sepharose 
solution (prepared by allowing 100 mg of protein A-Sepharose to swell in  1 ml 
of solution A for about 2 h, and resuspending the beads in I ml solution A after 
three  to  four washes) was added,  and the  mixtures  were  incubated at  room 
temperature for 2 h. The incubation mixtures were centrifuged in a microfuge for 
5 min, and washed three times with solution A. For the last wash Triton X-100 
was eliminated  from this solution.  The  samples were then  placed  in  sample 
buffer, and separated on a 6% polyacrylamide gel, containing 0.1% SDS. 
Co-assembly with Tubulin 
Labeled cultures were harvested by scraping in ice-cold reassembly buffer 
(RB: 0.1 M MES, pH 6.8; 1 mM EGTA; 0.5 mM MgCh; reference 12)) containing 
100  U/ml  aprotinin (Sigma Chemical  Co.)  0.5  mM  PMSF  and  1 mg/ml of 
disassembled three-times cycled bovine brain microtubules (12).  For cultures 
labeled with [a2P]-orthophosphate,  this and all subsequent solutions also contained 
20 mM nitrilotriacetic acid (NTA) to inhibit phosphatase activity (21).  The cell 
harvests were homogenized by  10 strokes in a  glass-glass homogenizer at 4°C 
and then incubated for 30 rain on ice to promote microtubule disassembly. The 
homogenate was then centrifuged for 30 min at 120,000 g in a Beckman airfuge 
(Beckman Instruments, Inc., Fullerton, CA) at 4°C. Essentially all of the labeled 
material co-migrating  with MAP 1 was found in the supematant. The supernatant 
fraction was then adjusted to contain 1 mM GTP and 4 M glycerol and incubated 
at 37°C for 30 min to promote assembly of microtubules (12). This material was 
centrifuged as above for 30 rain at 37°C, the supernatant was removed and the 
"microtubule" pellet was taken up in RB supplemented with inhibitors as above. 
After incubation on ice for 30 rain to promote dissassembly, this material was 
centrifuged as above at 4°C and the supernatant fraction collected. An aliquot of 
this "cycle 1" material was removed, mixed with an equal volume of 2× sample 
buffer, boiled and analyzed by SDS PAGE as described below. The remaining 
part of the supernatant was carried through a  second cycle of assembly by the 
procedure described above and the  resulting microtubule pellet  dissolved  in 
sample buffer, boiled, and analyzed by SDS PAGE. 
Taxol-facilitated Assembly 
Labeled cultures were harvested in RB containing 100 U/ml aprotinin, 0.5 
mM PMSF, 20 mM NTA, 0.5 percent Triton X-100, and 2  mg/ml of bovine 
brain tubulin which had been freed of MAPs by chromatography on phospho- 
cellulose (16). After homogenization, incubation on ice, and centrifugation at 
4°C,  all  as  described  above,  the  MAP-containing supernatant  fraction  was 
adjusted to contain l  mM GTP and 12 ~M taxol (22, 23) and incubated for 30 
min at room temperature (23).  This  mixture was then  centrifuged at 4°C  as 
above. The  supernatant was removed and processed for SDS  PAGE and the 
pellet  was washed once in  the  above buffer without  tubulin and Triton  and 
recentrifuged. The pellet was then suspended in 0.35 M NaCI in the above buffer 
without Triton but with taxol to solubilize MAPs as described by Vallee (23). 
This material was recentrifuged and the resulting super'natant and pellet fractions 
were processed for SDS PAGE. 
Thermostability 
Stability to boiling was determined by modifications of previously described 
procedures (20, 24). Labeled cultures were harvested in reassembly buffer con- 
taining 10 mM dithiothreitol, 40 mM NaC1,  100 U/ml aprotinin, 5 mM PMSF 
and 20 mM NTA and with or without -1  mg/ml of carrier three-times cycled 
disassembled bovine brain microtubules. The cellular material was homogenized 
as above and incubated for 10 min at 4°C to promote microtubule disassembly. 
The homogenate was then  centrifuged at  120,000 g  as above at 4°C and the 
supernatant fraction was transferred to a preheated glass tube in boiling water. 
After exactly 5  rain,  the  boiled fraction was rapidly cooled on  ice and then 
centrifuged at  120,000 g  at 4°C  for  30  rain.  Aliquots  of an  fractions were 
processed for SDS PAGE. 
SDS PAGE and Detection of Labeled Proteins 
Samples were  collected  and  boiled  in  sample  buffer as  described  above. 
Electrophoresis was carried out in the discontinuous system described by Laemmli 
(13) on slabs (25 or 9 cm) of either 6'/2-13% gradients of acrylamide or 5, 5Y2, or 
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high molecular weight MAPs. Samples of twice cycled microtubules  (to reveal 
the position of MAPs) and of molecular weight standards (myosin, M, 20@000; 
jS-galactosidase, MT 117,000; phosphorylase-b,  Mr 94,000; albumin,  Mr 68,000; 
ovalbumin, Mr 43,000, carbonic anlaydrase, Mr 30,000; soybean trypsin inhibitor, 
Mr ffi 20,000; lysozyme, Mr ffi 14,000; purchased from Bio-Rad Laboratories and 
Pharmacia, Inc., Piscataway, N J) were also loaded on each gel. After electropho- 
resis, the gels were fixed, stained, and destained as previously described (7). For 
samples containing |~2p], the gels were dried and incubated with Kodak XAR-5 
X-ray film. For samples containing [~S]-methionine, the slabs were impregnated 
with salicylate before drying (25), and then fluorographed  with preflashed (26) 
XAR-5 film. Because the salicylate impregnation greatly obscured the patterns of 
stained proteins, the Rf values of markers were determined before treatment. 
Indirect Immunofluorescent Staining 
PC 12 ceils were cultured on collagen-coated coverslips, either with or without 
NGF. In the former case, the cells were pretreated  with NGF for two wk and 
then passaged onto the coverslips and maintained  for an additional  6 d with 
NGF. Cultures were prepared for staining by several procedures: (a) ftxation for 
30 rain at room temperature with 4% paraformaldehyde  in PBS; (b) extraction to 
prepare stabilized cytoskeletons (27) followed by f'Lxation  as above; (c) pretreat- 
ment with 5 #g/ml taxol for 1 h followed by extraction and fixation as in (b). 
After being washed free of fLxative,  the cultures were incubated for 1 h with PBS 
containing  0.1% (vol/vol)  Triton X-100 and  !% normal goat  serum  and then 
incubated  for I h with either anti-HMW-MAP  antiserum  (1:50 and 1:200) or a 
monoclonal antibody to a-tubulin (1:1,000; kindly provided by Dr. S. Blose, Cold 
Spring Harbor). The coverslips were washed and then incubated with FITC-goat 
anti-rabbit  or anti-mouse antiserum (1:200; Cappel Laboratories Inc., Cochran- 
viUe, PA), washed and observed with a fluorescence microscope. All antibody 
dilution and washes were carried  out using PBS containing  Triton X-100 and 
normal goat serum as above. In some cases the anti-HMW-MAP antiserum was 
supplemented  with  excess MAP2  (-0.2  mg/ml) prepared by the method of 
Herzog and Weber (20). Parallel control cultures were incubated with the same 
dilution of preurtmune serum. 
MATERIALS:  NGF was prepared as described by Mobley et al. (28), EGF 
was prepared by the method of Savage and Cohen (29) and was the generous gift 
of Dr.  Fred  Maxfield  (Department of Pharmacology,  New York  University 
Medical Center),  insulin was from Eli Lilly Chemical  Co. (Indianapolis,  IN), 
dibutyryl cAMP was purchased  from Boehringer Mannheim Biochemicals (in- 
dianapolLs, IN),  and taxol  and camptotlieein  were supplied  by the National 
Cancer  Institute.  The pliosphocellulose-chromatographed  tubulin  and bovine 
brain microtubules were kindly provided by Dr. J.-F. Letterier, Department of 
Pharmacology, New York University Medical Center. 
RESULTS 
Effect of NGF on Phosphoproteins 
To  identify  changes  in  phosphoproteins  caused  by  NGF, 
PC12  cultures  were treated  with the  factor for various  times 
(from  several  hours  to  several  weeks)  and  then  exposed  to 
[32p]-orthophosphate for 2  h.  NGF  was present during  phos- 
phorylation except for control, non-NGF-treated  cultures. The 
labeled  phosphoproteins  were  then  resolved  by  SDS  PAGE 
and  visualized  by  radioautography.  The  results  of one  such 
experiment are  shown in  Fig.  1.  A  marked  increase in phos- 
phorylation of a  band at about Mr =  60,000 was noted by 2  h. 
After a  week of NGF  treatment,  this band  was  substantially 
less prominent. A  second band at Mr =  56,000  also showed a 
transient  increase,  while  a  minor  band  at  Mr  =  64,000  was 
enhanced at 2 h  of NGF  exposure and remained elevated even 
after  a  week of NGF  treatment.  An  additional  faint band  at 
Mr  =  72,000  showed enhancement  only after  2-3  d  of NGF 
exposure.  The  most  striking  change,  however,  occurred  in  a 
very high molecular weight (Mr ~  300,000)  band that showed 
an increased labeling  by about  2  d  of NGF  treatment  and  a 
progressive enhancement of labeling thereafter. 
Because  of the  magnitude  of  the  latter  change,  the  high 
molecular weight (HMW)  phosphoprotein was chosen for fur- 
ther study. To facilitate resolution of the high molecular weight 
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FIGURE  1  Pattern of phosphoproteins in PC12 cells as a function of 
the time of exposure to NGF.  Cultures were incubated with  [32p]_ 
orthophosphate for 2 h either without NGF pretreatment (0 and 0.1 
d)  or after pretreatment as indicated. Except for the 0  time point, 
NGF was present during the incubation. At the end of this time of 
incubation, the cultures were prepared and resolved by SDS PAGE 
as described in Materials and Methods. Resolution was on 61/2-13% 
acrylamide  gel  (25  cm  in  length);  100,000 TCA-precipitable cpm 
were loaded in each lane. Radioautography was for 2 d. Arrowheads 
indicate the positions of bands whose relative intensities are altered 
in  response  to  NGF  treatment.  Numbers  on  the  left-hand  side 
indicate the position of molecular weight markers (mol wt x  10-3). 
range, gels with a  lower percentage of acrylamide (5-6%) were 
employed. 
Specificity  of and Requirements  for the HMW 
Phosphoprotein  Response 
In addition to NGF,  several other agents have been reported 
to elicit responses from PC12  cells.  These agents include epi- 
dermal growth factor (EGF;30),  insulin (31), dibutyryl cAMP 
(32,  33),  and dexamethasone (34).  Although such compounds do not mimic many of the actions of NGF (e.g., promotion of 
neurite outgrowth) they do possess some actions in common 
with NGF. To test the specificity of the response of the HMW 
phosphoprotein,  PC12  cultures  were  phosphorylated  either 
during 2  h  or following 7-10  d  of treatment with the above 
agents (EGF, 1 and 10ng/ml; insulin 100 ng/ml; dB cAMP,  1 
mM;  dexamethasone,  1 and  10 #M;  NGF,  50  ng/ml).  Phos- 
phorylation of the Mr ~  300,000  band was changed only by 
NGF. An example of an experiment on cells treated for 8 d 
with and without several of these compounds is shown in Fig. 
2.  Also,  when  given  in  combination  with  NGF,  the  above 
agents did not alter NGF's long term effect on the HMW band. 
Because  PC12  cells can  be  maintained  in  the  absence  of 
serum if NGF is present (35), it was possible to test whether 
serum  components  in  complete  medium  were  required  for 
enhanced labeling of the HMW band. As illustrated in Fig. 3, 
the action of NGF occurred in serum-free medium. 
A  number  of responses  of PCI2  cells to  NGF  appear  to 
require  transcription since they  become  apparent only after 
several days of treatment and are blocked by low concentra- 
tions of RNA synthesis inhibitors (3, 5). The slow time course 
(Fig.  1) of the effect of NGF on  the  HMW phosphoprotein 
suggested this might also be so in this instance. In agreement 
with this possibility, enhancement of the HMW band by NGF 
DGURE  3  Induction by NGF of the HMW  phosphoprotein in sus- 
pension culture (B and C) and in defined, serum-free medium (D, 
E, and F ). For the suspension experiment, PC12 cells were grown for 
12 d  in suspension with  (C) or without (B)  50 ng/ml  NGF.  For the 
serum-free  experiment,  PC12 cells  were  grown  for  8  d  either  in 
complete  medium  without  (D)  or with  (E)  50  ng/ml  NGF  or  in 
serum-free RPMI 1640 medium with 50 ng/ml NGF (F). All cultures 
were exposed to  [32P]-orthophosphate for 2 h with  the continued 
presence or absence of  NGF  and then  processed and  resolved by 
SDS  PAGE  in  6%  polyacrylamide gels.  ~100,000  TCA-precipitable 
cpm were loaded per lane; autoradiography was for I  d. Lane A was 
loaded on the same gel as B and  C with  bovine brain microtubule 
proteins and stained with Coornassie Blue. The left- and right-hand 
sides  indicate  the  positions  of  MAP  1  and  MAP  2  as well  as  of 
molecular weight markers (tool wt x  10  -3)  all loaded on the same 
gels. 
FIGURE  2  Specificity of effect of NGF on  the HMW  phosphopro- 
tein. PC12 cultures were grown for 8 d in the presence of no additive 
(contr.), NGF (50 ng/ml), epidermal growth factor ( EGF; 10 ng/ml); 
insulin  (100 ng/ml) or dibutyryl cAMP (DB cAMP; 1 mM) and then 
exposed to [32P]-orthophosphate in the presence of the same com- 
pounds. The cells were then processed and resolved by SDS PAGE 
(6%  acrylamide)  as  described  in  Materials  and  Methods;  100,000 
TCA-precipitable counts  were  loaded  per  lane.  Radioautography 
was for 1 d. The left-hand  lane was  loaded on the same gel with 
bovine brain microtubule proteins (MT) and stained with Coomassie 
Blue. The left-hand side indicates the positions of MAP 1 and MAP 
2 as well  as the positions of  molecular weight  markers (tool wt x 
10-3). 
was inhibited by 0.2/~g/ml of camptothecin and 0.01/~g/ml of 
actinomycin-D. 
Enhancement of the HMW phosphoprotein in PC 12 cultures 
occurs with about the same time course as promotion of neurite 
outgrowth.  Might the  former  then  be  a  consequence  of the 
latter? To test this, PC 12 cells were maintained with or without 
NGF in suspension culture for 10-21  d and then labeled with 
[32P]-orthophosphate as described in the Materials and Meth- 
ods section. Under these circumstances, the suspended NGF- 
treated cells do not form neurites (9), but nevertheless appear 
to undergo the metabolic and transcriptional changes required 
for neurite  production.  This  is illustrated by their ability to 
commence neurite outgrowth almost immediately upon being 
plated on an adhesive substrate, even if their RNA synthesis is 
blocked (9). As illustrated in Fig. 3, enhancement of the HMW 
phosophoprotein also occurred under these circumstances. 
Cross-reactivity  of HA IW Phosphoprotein with 
Brain HMW MAPs 
Due to its apparent size and phosphorylation, the possibility 
arose that the  HMW phosphoprotein might correspond to  a 
HMW microtubule-associated  protein (or HMW MAP). HMW 
MAPs are phosphoproteins that co-purify with brain tubulin 
through  repeated  cycles  of  assembly  and  disassembly  and 
which have electrophoretic mobilities by SDS PAGE of Mr 
300,000 (cf. references 14--16, 20,  23). The HMW MAPs have 
been subclassified as MAP 1 and MAP2, the former of some- 
what slower mobility by SDS PAGE (14-16,  20, 23, and see 
Figs. 2-6). Each of these in turn can be further resolved into at 
least two distinct bands (termed here MAPs 1.1, 1.2, 2.1, and 
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phosphoprotein consistently co-migrated with MAP1, and at 
higher resolution, with the more rapidly migrating MAPI.2. 
To test the possibility that the HMW phosphoprotein cor- 
responds  to a  HMW MAP,  PC12  cells  were treated  with or 
without NGF for 10-16 d, phosphorylated for 2 h, solubilized 
in  1%  SDS  in the  presence  of inhibitors  of proteolysis,  and 
equal  numbers  of TCA-precipitable  cpm from each  type of 
culture were subjected to immunoprecipitation with antiserum 
directed against purified HMW MAPs. When the immunopre- 
cipitates  were  analyzed  by  SDS  PAGE,  a  major  band  was 
observed that co-migrated with MAP1.2 (for example see Fig. 
4 E-H). In addition, the relative intensities of these bands from 
cultures maintained with and without NGF reflected the dif- 
ferences in intensities  of these  bands  in the original cell ho- 
mogenates. The immunoprecipitations were not blocked by the 
addition of excess (1 mg/ml) MAP2 protein. If the proteolytic 
inhibitors were omitted, a  second labeled band appeared that 
had a mobility slightly faster than MAP2. 
Similar experiments were also performed with PC 12 cultures 
labeled  for 48-72 h  with  [32S]-methionine.  A  major band of 
identical mobility with the phosphorylated band was specifi- 
cally  immunoprecipitated  (Fig.  4A-D).  Significantly,  even 
though equal numbers of TCA-precipitable cpm were used for 
immunoprecipitation, the band from the NGF-treated cultures 
was  again  more  intense.  This  suggests  that  NGF  causes  an 
increase  in the absolute  amount of this  protein which is  de- 
tectable either by labeling with [~sS]-methionine  or [32P]-ortho- 
phosphate. 
Association of the HMW  Protein  with 
Microtubules 
Two types of experiments were performed to test whether 
the NGF-affected protein could associate with microtubules. 
PC12  ceils  treated  with  or without  NGF  were  labeled  with 
[a~S]-methionine  or [asP]-orthophosphate, homogenized under 
microtubule-destabilizing  conditions  and  then  centrifuged  at 
high speed (see Materials and Methods). The HMW phospho- 
protein  and  a  corresponding  methionine-labeled  band  were 
found to be present predominantly in the supernatant fraction. 
In one type of experiment, the latter fraction was submitted to 
several consecutive cycles of assembly-disassembly in the pres- 
ence of excess purified brain microtubules (see  Materials and 
Methods).  Fig.  5  illustrates  an experiment with  [aSS]-methio- 
nine-labeled cultures that had been treated with NGF. A high 
molecular weight band co-migrating with MAP 1.2 was highly 
enriched through two cycles of co-assembly. In contrast, when 
similar levels of TCA-precipitable radioactivity derived  from 
NGF-untreated  cultures  were  co-cycled,  this  band  was  not 
detected, even after the first cycle. Similar results were achieved 
with [a2P]-orthophosphate-labeled cultures.  In addition to the 
Mr ~  300,000  band,  as illustrated  in Fig. 5, a  band of M~ = 
210,000  was also highly enriched upon co-cycling. A  second 
type of experiment involved the use of taxol, an alkaloid that 
greatly promotes  assembly  and  stabilization  of microtubules 
(36).  As recently described  by Vallee  (23),  MAPs associated 
with taxol-stabilized tubules can be quantitatively solubilized 
with high salt while leaving the tubules intact. Labelled super- 
natant  fractions prepared  as described above were incubated 
in the presence of purified MAP-free brain tubulin and taxol 
(see Materials and Methods). The mixture was then centrifuged 
at high speed to pellet the resulting microtubules. For both the 
[a2p]_ and  [3~S]-labeled  cultures,  a  band  co-migrating  with 
MAP 1.2 was present in the supernatant prior to taxol addition 
and,  after  taxol  polymerization,  was  nearly  quantitatively 
shifted to the pellet fraction. Fig. 6 illustrates an experiment in 
which the washed taxol-assembled microtubule pellet was ex- 
posed to 0.35 M NaC1 to solubilize MAPs. Note that the band 
co-migrating with MAP 1 is nearly quantitatively removed from 
the original supernatant fraction after taxol treatment (lanes B 
and C) and then solubilized by the salt treatment (lanes D and 
E). 
FIGURE  4  Immunoprecipitation  with  anti-MAPs.  Lanes  A  and  C 
show the specific immunoprecipitation of [35S]-methionine-labeled 
material  from  NGF-treated  and  untreated  cultures  respectively, 
whereas B and D are controls in which preimmune serum was used. 
Lanes E and G are immunoprecipitates from [32P]-orthophosphate- 
labeled cultures  with  (E)  and without  (G)  NGF.  F and  H  are the 
corresponding controls  with  preimmune  serum.  [a%]-methionine 
labeling was for 2 d after 11 d of culture with  (A and  B) or without 
(C and  D)  NGF.  Labeling with  [a2P]-orthophosphate was  for  2  h 
after  13  d  culture  with  (E  and  F)  and  without  (G  and  H)  NGF. 
Aliquots  containing  500,000 TCA-precipitable cpm  were  used  for 
immunoprecipitation  in  each case and the entire  immunoprecipi- 
tates  were dissolved and  loaded on  the gel  (5%  acrylamide).  Ra- 
dioautography was for 11  d.  Lane  I shows the positions of stained 
HMW  MAPs  in  a  sample  of  bovine  brain  microtubule  proteins 
loaded on the same gel. 
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FiGure  5  Co-cycling  of  PC12 
HMW  MAPs with  brain  microtu- 
bules.  PC12 cultures  were  main- 
tained with NGF for 10d and then 
labeled in  complete medium  for 
48  h  with  [35S]-methionine.  The 
cultures  were  homogenized,  a 
high speed supernatant was  pre- 
pared (SUPNT) and the material 
was  processed through  two con- 
secutive  cycles  of  assembly  and 
disassembly with carrier brain mi- 
crotubule  proteins.  Left-hand 
lane, 50,000 TCA-precipitabte cpm 
of high speed supernatant; middle 
lane 6,800 TCA-precipitable cpm 
from  the  disassembled  microtu- 
bule pellet of  Cycle 1; and  right- 
hand lane, 2,300 TCA-precipitable cpm from the microtubule pellet 
of cycle  2. Resolution was by SDS PAGE on 5% acrylamide gels and 
visualization by 1 (5UPNT)  and 10 (cycles  1 and 2) days of fluorog- 
raphy. Left-hand side indicates positions in the same gel of stained 
bovine brain  microtubule  HMW  MAPs  (1.1, 1.2, 2.1, and 2.2  from 
top) and of molecular weight standards (tool wt x  10-3). FIGURE  6  Co-assembly  of 
PC12 HMW  MAP with  tu- 
bulin  in  the  presence  of 
taxol and its release by high 
salt.  PC12 cultures  were 
maintained with  NGF for 7 
d  and  then  labeled  with 
[3%]-methionine  in  com- 
plete medium  for 3 d. The 
cultures  were  homoge- 
nized  in  the  presence  of 
carrier tubulin  (A), a high- 
speed  supernatant  was 
prepared (B) and the latter 
was  treated  with  taxol  as 
described in Materials and Methods and centrifuged at high speed. 
An aliquot of the supernatant fraction from the latter centrifugation 
is  shown  in  lane  C.  The  pellet was  washed  once,  suspended  in 
buffer containing 0.35 NaC[ and recentrifuged at high speed. Lanes 
D and  Econtain material from the resulting supernatant and pellet, 
respectively. Approximately 40,000 (A-C), 6,000 (D), and 4,200 (E) 
TCA-precipitable counts were loaded. Resolution was by SDS PAGE 
on  5% acrylamide gels.  Fluorography was for  13 d.  Left-hand  side 
indicates  positions of  stained  HMW  MAPs  (1.1, 1.2, 2.1, 2.2, from 
the  top)  and  of  molecular weight  standards  (mol  wt  x  10  -3  )  all 
loaded on the same gel. 
Thermal Lability of the HM W  Phosphoprotein 
The mobility of the NOF-responsive phosphoprotein sug- 
gests that  it corresponds to  MAP1  rather  than  to  MAP2.  A 
distinguishing feature between  MAP1  and  MAP2 is that the 
latter, but not the former is stable to boiling (20,  24).  NGF- 
treated and -untreated PCI2 cultures were labeled with [32p]_ 
orthophosphate, homogenized in the presence of depolymer- 
ized carrier microtubules and soluble supernatants were pre- 
pared as described above. These were then boiled for 5 min as 
described in Materials and Methods. As illustrated in Fig. 7, as 
a  result of this treatment, the HMW phosphoprotein was lost 
from  the  supernatant  fractions.  This  material  could  be  re- 
covered  however,  from  the  precipitate fraction  that  formed 
upon  boiling  (data  not  shown).  Panels  C  and  F  of Fig.  7 
demonstrate that the susceptibility of the HMW phosphopro- 
tein  to  boiling  was  not  affected  by  the  absence  of carrier 
microtubule  proteins.  Staining  of the  gels  revealed  that  as 
expected, the carrier MAPI, but not MAP2, was lost from the 
supernatant upon boiling. 
Immunofluorescent  Staining 
The presence of HMW MAPs in PCI2 processes was dem- 
onstrated by indirect immunofluorescence.  Staining with the 
antiserum  against HMW  MAPs was  evident (in  comparison 
with controls processed with preimmune serum) in all neurites 
as well as in the somas of NGF-treated cells. Positive, though 
apparently significantly less intense, staining was also obtained 
with  NGF-untreated  cultures.  Identical patterns  of staining 
were  observed with  anti-HMW-MAP antiserum to which  an 
excess (-0.2 mg/ml) of purified MAP2 had been added.  Fi- 
briUar staining was not seen in any of the cells. Positive staining 
of somas and processes was also present with stabilized cyto- 
skeletal preparations of the  cultures,  both  with  and  without 
pretreatment with taxol, but again a fibriUar pattern could not 
be  detected.  The  absence  of fibrillar staining  is  difficult  to 
interpret because the  free caliber of the  PCI2 processes may 
have precluded such  an observation. In support of the latter 
possibility, monoclonal anti-a-tubulin presented a strongly pos- 
FIGURe  7  Thermal  lability of  the  NGF-responsive MAP.  Cell  cul- 
tures were grown for 10 d  in the presence or absence of 50 ng/ml 
NGF and labeled for 2 h with  [32P]-orthophosphate under the same 
conditions. Cultures were then  homogenized, centrifuged  at  high 
speed, and the supernatants boiled, cooled, and recentrifuged  (see 
Materials and Methods).  Carrier microtubule  proteins were added 
to samples A,  8,  D, and E and omitted from  C and F. Lanes A  and 
D  are from the supernatants of cultures grown without NGF before 
and after boiling, respectively. Lanes B and C are from NGF-treated 
cultures before boiling whereas E and F are from the same cultures 
after boiling.  ~30,000  TCA-precipitable cpm  were loaded per lane 
and  autoradiography was  for  4  d.  The  positions  of  microtubule 
associated proteins and molecular weight standards in the same gel 
are indicated at left (mol wt X  10-3). 
itive but nonfibrillar pattern of staining with both whole cell 
and stabilized cytoskeletal preparations. 
DISCUSSION 
Rapid Effects of NGF on 
Protein  Phosphorylation 
Our results corroborate previous reports (37, 38) that NGF 
evokes rapid changes in phosphorylation of selected proteins 
in PCI2 cultures. In particular, the Mr =  60,000 band appears 
to correspond to the band identified by Halegoua and Patrick 
(38) as tyrosine hydroxylase. The cause of the fall off of relative 
labeling of this species after several days is not clear, but could 
correlate with  the  drop  in  tyrosine hydroxylase activity that 
occurs in PC 12 cultures after a similar period of  NGF treatment 
(2).  The effect of NGF on the Mr =  56,000 and 64,000 bands 
appear to have been previously undescribed. The significance 
of such  changes is not clear, but as suggested previously for 
NGF (37, 38) as well as for rapid phosphorylations triggered 
by other peptide hormones,  these could play a  causal role in 
subsequent cellular responses. 
Induction  of MAPs 
The present studies reveal that NGF significantly induces 
the level of a high molecular weight phosphoprotein in PC12 
pheochromocytoma cells. Evidence for the identification of this 
protein as  a  MAP  include its (a)  cross-reactivity with  brain 
HMW MAPs, (b) co-association with tubules through several 
cycles of assembly and disassembly, and (c) quantitative assem- 
bly with tubulin in the presence of taxol and its quantitative 
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thermore the induced species appears to correspond to MAP 1 
rather than MAP2, as indicated by its co-migration with brain 
MAPI in SDS PAGE gels, its lability  to boiling, and the failure 
of excess MAPs to block its immunoprecipitation. High-reso- 
lution SDS PAGE in 5% acrylamide gels further indicated co- 
migration with MAP1.2. Because the molecular properties of 
HMW MAPs are largely unknown,  one cannot yet ascertain 
whether  the  induced  PCI2  MAP  is  identical to  previously 
described brain HMW MAPs. 
HMW MAPs are found in relative abundance in brain (14- 
16,  20,  24).  MAP2  appears  to  be  significantly enriched  in 
neuronal  dendrites  (39),  whereas  MAPI  may  have  a  more 
widespread neural distribution (23). A variety of different types 
of experiments (16,  20,  24)  suggest  that  HMW  MAPs  may 
promote  the  formation  and  stabilization of microtubules as 
well as cross-link these structures with other elements of the 
cytoskeleton (40).  There is also abundant evidence that micro- 
tubules are required for the production and maintenance  of 
neurites by neurons (41, 42) as well as by NGF-treated PCI2 
cells (9).  Hence, it is reasonable to speculate that one step in 
the mechanism of action of NGF is the induction of MAP1 
protein, which in turn enhances the formation and/or stabili- 
zation of microtubules. This could play a  major role in pro- 
motion and maintenance of neurite outgrowth. The presence 
of MAP1 in PC 12 neurites, as revealed by immunofluorescent 
staining, is consistent with this hypothesis. 
Of particular relevance to the above possibility is the recent 
Finding  that  long-term  treatment  of PCI2  cells  with  NGF 
appears to alter the properties of their microtubules (27).  That 
is, microtubules in neurite-bearing PC 12 cells exposed to NGF 
for 3 wk are considerably more resistant to the depolymerizing 
effects of colchicine than  are microtubules in PC12  cultures 
grown either without NGF or with NGF for 24 h. Also, MAPs 
are reported to decrease the susceptibility of microtubules to 
calcium-induced depolymerization in vitro (43). 
MAP  Induction  and  Priming 
Prior experiments have provided evidence for a  "priming" 
mechanism  whereby NGF  promotes via a  slow-onset, tran- 
scription-dependent mechanism, the synthesis and accumula- 
tion  of material that  is  required  for neurite outgrowth  and 
elongation (5, 9). As for priming and neurite outgrowth, induc- 
tion  of phosphorylated MAP1  by  NGF  was  found  here  to 
follow a lag of 1-2 d, to increase progressively thereafter and 
to  require de novo  synthesis of RNA.  Also, as for priming, 
induction  of MAP I  occurred  in  suspension  and  was  hence 
independent  of neurite outgrowth  and  substrate attachment. 
Finally, treatments with a variety of agents that elicit responses 
from PC12 cells but that do not cause priming, did not induce 
phosphorylated MAPI.  Hence,  these Findings are consistent 
with the possibility that induction of MAP 1 by NGF could be 
one of the molecular correlates of priming. 
PC72 Cell MAPs 
Aside from MAPI, our data suggest that PCI2 cells possess 
at least several other HMW MAPs. Very long overexposure of 
radioautographs of material immunoprecipitated from labeled 
cultures, as well as of microtubules produced by cycling and 
taxol-treatment of such  cultures, indicates the presence of a 
relatively small  amount  of  material  that  co-migrates  with 
MAP2.  The  relative labeling of this material appears to  be 
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unaffected by NGF treatment and it appears to be stable to 
boiling (see Fig. 6 for example). In addition, analysis of micro- 
tubules formed by co-cycling and taxol treatment of labeled 
cultures indicates the presence of a  phosphoprotein MAP of 
apparent Mr =  200,000-225,000  in NGF-treated cultures (see 
Figs.  5  and  6).  It  has  not  yet  been  possible to  detect  this 
material in corresponding experiments with NGF-untreated 
cultures.  The  "boiling" experiment  shown  in  Fig.  7  further 
indicates  that  a  heat  stable  phosphoprotein  of this  size  is 
considerably enhanced in N GF-treated cultures. It is of interest 
that a MAP of about this size has been reported to be induced 
in "differentiated" murine neuroblastoma cultures (44) and to 
be present in certain nonneural cells (45, 46). However, further 
experiments will be necessary to further substantiate the iden- 
tity of these and other putative MAPs in PC 12 cells. 
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